MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4874 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-04-16 (medtechdive.com)
J&J's electrophysiology sales dip amid slow Varipulse start |
Johnson & Johnson's electrophysiology unit struggled in the first quarter, as the company chases Medtronic and Boston Scientific in the red-hot pulsed field ablation market.
Read more
2025-04-15 (globalgrowthinsights.com)
Surgical Stapling Devices Market Size, Share, Growth, and Industry Analysis, By Types (Straight Surgical Stapling Devices, Curved Surgical Stapling Devices, Circular Surgical Stapling Devices, Others) , Applications (Gastrointestinal Surgery, Gynecologic Surgery, Thoracic Surgery, Others) and Regional Insights and Forecast to 2033
Surgical Stapling Devices market size is estimated at USD 4304.5 Million in 2025 and is expected to reach USD 8026.5 Million by 2033 at CAGR of 8.1%.
Read more
2025-04-14 (openpr.com)
The Surgical Equipment Market Set to Double by 2030: Key Drivers and Innovations
Press release - MAXIMIZE MARKET RESEARCH PVT. LTD. - The Surgical Equipment Market Set to Double by 2030: Key Drivers and Innovations - published on openPR.com
Read more
2025-04-08 (mddionline.com)
Market Expectations for Transcatheter Mitral Valve Replacement Devices Rebounding Market Expectations for Transcatheter Mitral Valve Replacement Devices Rebounding
In 2025, the transcatheter mitral valve replacement (TMVR) market is experiencing significant growth, driven by innovative devices, positive patient trial results, and advancements like robotic-assisted procedures, despite ongoing challenges in treatment development.
Read more
2025-04-02 (medtechdive.com)
3 takeaways from ACC 2025 |
Medtronic, Abbott and Boston Scientific had updates on their devices used in heart valve disease treatment at the event.
Read more
2025-03-10 (massdevice.com)
Medtronic's SMART trial shows positive Evolut TAVR performance in small aortic annulus patients
Medtronic released positive two-year trial Evolut TAVR results that demonstrated superior valve performance in small aortic annuli patients.
Read more
2025-02-08 (evtoday.com)
Medtronic’s DiVERT Stroke Study Evaluated Sex-based Disparities in Post-stroke Cardiac Care -
February 6, 2025—Medtronic announced that new findings from the company-sponsored DiVERT Stroke clinical study showed women spent less time in t
Read more
2025-02-06 (biospace.com)
New Study Highlights Positive Impact of Viz.ai on Enhancing Post-Stroke Patient Care -
Clinical study results demonstrate Viz.ai and Medtronic collaboration has helped improve cardiac monitoring utilization, care efficiency, and patient satisfaction with Viz Connect® care pathway
Read more
2025-02-05 (newsmachine.com)
Sahlgrenska University Hospital and Medtronic collaborate for the future care - Sahlgrenska University Hospital
Strategic partnership: Medtronic and Sahlgrenska University Hospital are entering a strategic partnership on the development of future care.
Read more